Democrats have a golden opportunity to lower drug prices — again — before the next Congress begins on Jan. 3. Democrats and ...
March-in rights are vital safeguards that allow the federal government to license competitors when the owner is not making a ...
With policy makers focusing on the role of drug manufacturers, almost no attention has been paid to the way in which ...
My mechanic works nights at the grocery store.His wife is sickly. Her medications are costly.So he works two jobs. One is for ...
It's not surprising that drug makers oppose Maryland's efforts to limit prices of some prescription drugs, write Sean Tunis ...
The Inflation Reduction Act is unlikely to generate savings for taxpayers, while disrupting the market and creating perverse ...
A handful of pharmacy benefit management companies, or PBMs, are being sued for running up the price on certain prescription medications. The PBMs also are the source of increasing financial ...
Oregon DCBS to host a public hearing on drug prices, focusing on advertising costs, rebates, and consumer impact, on December 4.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback